Literature DB >> 2455685

The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45.

L A Terry1, M H Brown, P C Beverley.   

Abstract

The leucocyte-common antigen (L-CA or CD45) is a family of high molecular weight glycoproteins, ranging from 180,000 to 220,000 MW that are expressed only on cells of lymphoid and myeloid origin. CD45 monoclonal antibodies (mAbs) recognize epitopes present on all polypeptides of the family, while other mAbs, termed CD45R, recognize determinants found only on the 220,000 MW and 200,000 MW polypeptides. In contrast the mAb UCHL1 recognizes a 180,000 MW antigen. UCHL1-coupled Sepharose beads were used to absorb antigen from lysates of cell lines. CD45 mAbs bound to this immobilized antigen. Antigen immobilized with CD45 mAb-coupled Sepharose beads bound UCHL1. Antigen purified by absorption and elution from the MOLT-4 cell line with CD45 mAb-coupled beads yielded molecules of 180,000 and 190,000 MW. Reprecipitation of the eluted antigen with UCHL1 resulted in a 180,000 MW band only. In a reciprocal experiment, CD45 mAb reprecipitated a 180,000 MW molecule from purified UCHL1 antigen. UCHL1 and the CD45R mAb 2H4 showed a mutually exclusive pattern of reactivity with human T- and B-cell lines, but co-expression of the antigens was seen on two myeloid and one erythroleukaemic cell line. In contrast, epitopes recognized by other putative CD45R mAbs were co-expressed with UCHL1 both on myeloid, erythroid and many T- and B-cell lines. We conclude that UCHL1 recognizes an epitope present only on the 180,000 MW polypeptide of CD45. Expression of this antigen is essentially reciprocal to the epitope detected by the CD45R mAb 2H4.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2455685      PMCID: PMC1384964     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Subpopulations of T lymphocytes.

Authors:  D W Mason
Journal:  Immunol Lett       Date:  1987-04       Impact factor: 3.685

3.  Inhibition of natural killer-cell mediated cytolysis with monoclonal antibodies to restricted and non-restricted epitopes of the leucocyte common antigen.

Authors:  G C Starling; S E Davidson; J L McKenzie; D N Hart
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

4.  The predominant heavily glycosylated glycoproteins at the surface of rat lymphoid cells are differentiation antigens.

Authors:  R Standring; W R McMaster; C A Sunderland; A F Williams
Journal:  Eur J Immunol       Date:  1978-12       Impact factor: 5.532

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Participation of histocompatibility antigens in capping of molecularly independent cell surface components by their specific antibodies.

Authors:  L Y Bourguignon; R Hyman; I Trowbridge; S J Singer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

Review 7.  Human T cell subsets.

Authors:  P C Beverley
Journal:  Immunol Lett       Date:  1987-04       Impact factor: 3.685

8.  Immunological properties of murine thymus-dependent lymphocyte surface glycoproteins.

Authors:  I S Trowbridge; C Mazauskas
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

9.  Quantitative serological analysis of a rabbit anti-rat lymphocyte serum and preliminary biochemical characterisation of the major antigen recognised.

Authors:  J W Fabre; A F Williams
Journal:  Transplantation       Date:  1977-04       Impact factor: 4.939

10.  Subpopulations of normal and leukemic human thymocytes: an analysis with the use of monoclonal antibodies.

Authors:  K F Bradstock; G Janossy; G Pizzolo; A V Hoffbrand; A McMichael; J R Pilch; C Milstein; P Beverley; F J Bollum
Journal:  J Natl Cancer Inst       Date:  1980-07       Impact factor: 13.506

View more
  39 in total

1.  Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-CD45R monoclonal antibodies.

Authors:  M N McCall; D M Shotton; A N Barclay
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

2.  CD22-mediated stimulation of T cells regulates T-cell receptor/CD3-induced signaling.

Authors:  A Aruffo; S B Kanner; D Sgroi; J A Ledbetter; I Stamenkovic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  CD27- CD4+ memory T cells define a differentiated memory population at both the functional and transcriptional levels.

Authors:  Asa Schiött; Malin Lindstedt; Bengt Johansson-Lindbom; Erwin Roggen; Carl A K Borrebaeck
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

4.  UCHL1+ (CD45RO+) 'memory' T cells predominate in the CD4+ cellular infiltrate associated with allergen-induced late-phase skin reactions in atopic subjects.

Authors:  A J Frew; A B Kay
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

5.  Monoclonal antibody OPD4 is reactive with CD45RO, but differs from UCHL1 by the absence of monocyte reactivity.

Authors:  S Poppema; R Lai; L Visser
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

6.  Relationships between 2H4 (CD45RA) and UCHL1 (CD45RO) expression by normal blood CD4+CD8-, CD4-CD8+, CD4-CD8dim+, CD3+CD4-CD8- and CD3-CD4-CD8- lymphocytes.

Authors:  S J Richards; R A Jones; B E Roberts; D Patel; C S Scott
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

7.  The development of primed/memory CD8+ lymphocytes in vitro and in rejecting kidneys after transplantation.

Authors:  A N Akbar; P L Amlot; A Timms; G Lombardi; R Lechler; G Janossy
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

8.  Phenotypic changes associated with activation of CD45RA+ and CD45RO+ T cells.

Authors:  D L Wallace; P C Beverley
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

9.  Monocyte chemoattractant protein-1 in human atheromatous plaques.

Authors:  N A Nelken; S R Coughlin; D Gordon; J N Wilcox
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

10.  Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: a pathological study of one autopsied case.

Authors:  G Sobue; M Doyu; M Watanabe; F Hayashi; T Mitsuma
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.